<DOC>
	<DOCNO>NCT01259128</DOCNO>
	<brief_summary>The purpose study determine SER120 nasal spray well tolerate 75 year old nocturic patient .</brief_summary>
	<brief_title>Study Investigate Safety Pharmacokinetics SER120 Nasal Spray Elderly Patients With Nocturia</brief_title>
	<detailed_description>Patients enter study randomize either Level 1 SER120 nasal spray concentration Level 2 SER120 nasal spray concentration</detailed_description>
	<mesh_term>Nocturia</mesh_term>
	<criteria>Male &amp; female great equal 75 year age , history nocturia CHF , Diabetes , Diabetes Insipidus , Renal Insufficiency , Heptatic Insufficiency , Incontinence , Illness require steroid , current past urologic maliganancy , nephrotic syndrome Unexplained pelvic mass Urinary bladder surgery radiotherapy Sleep apnea</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>